Phillip Kingma, MD
Interventional Pain Medicine · Carmel, INNPI 1629038419
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Vertos Medical, Inc. at 54.7% of the total. Reporting peaked in 2022 at $970 and has fallen 54.6% since, to $440 in 2025.
Across 186 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$3K
- Abbott$2K
- Painteq LLC$72
- Biodelivery Sciences International, Inc.$60
- Assertio Therapeutics, Inc.$58
- Pfizer$46
- plus $284 from 12 others
What the payments were for
- Food & beverage$4,75099%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 41 | $2,611 |
| Abbott | 113 | $1,643 |
| Painteq LLC | 2 | $72 |
| Biodelivery Sciences International, Inc. | 5 | $60 |
| Assertio Therapeutics, Inc. | 3 | $58 |
| Pfizer | 3 | $46 |
| Saluda Medical Americas, Inc. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 3 | $40 |
| Medtronic | 2 | $29 |
| Boston Scientific | 1 | $29 |
| Kaleo, Inc. | 2 | $29 |
| Almatica Pharma LLC | 2 | $24 |
| AstraZeneca | 2 | $23 |
| Nevro Corp. | 1 | $18 |
| Medline Industries LP | 1 | $16 |
| Pernix Therapeutics Holdings, Inc. | 1 | $13 |
| Vertiflex, Inc. | 1 | $11 |
| MDD US Operations, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$1,148
- PROCLAIM$128
How this compares
$4,774 in reported general payments places this provider in the 55th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 105 | $749 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 66 | $602 |
| Oxycodone Hcl | 24 | $116 |
| Gabapentin | 21 | $105 |
| Naproxen | 13 | $80 |
| Diazepam | 100 | $80 |
| Tramadol Hcl | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Carmel
- Joshua WellingtonCarmel$315K
- Dean MarianoCarmel$2K
- Joseph RutledgeLafayette$96K
- Orlando LandrumElkhart$34K
- Mahendra SanapatiEvansville$31K
- Nikhil ShettyMunster$29K
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
- Jocelyn BushIndianapolis$20K
- Scott KimGreenwood$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.